Carl Zeiss Meditec AG (XSWX:AFX) Price-to-Tangible-Book: (As of Sep. 01, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:AFX Carl Zeiss Meditec AG XSWX:AFX
76 GF Score
Price CHF29.80
GF Value CHF68.36
! 3 Warning Signs
View Full Analysis

What is Carl Zeiss Meditec AG Price-to-Tangible-Book?

As of today (2026-09-01), Carl Zeiss Meditec AG's share price is CHF29.80. Carl Zeiss Meditec AG's Tangible Book per Share of Dec. 2025 for the quarter that ended in Dec. 2025 was CHF0.00. Hence, Carl Zeiss Meditec AG's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Carl Zeiss Meditec AG's Price-to-Tangible-Book or its related term are showing as below:

XSWX:AFX' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 3.67   Med: 7.63   Max: 17.68
Current: 5.82

During the past 13 years, Carl Zeiss Meditec AG's highest Price to Tangible Book Ratio was 17.68. The lowest was 3.67. And the median was 7.63.

XSWX:AFX's Price-to-Tangible-Book is ranked worse than
76.25% of 699 companies
in the Medical Devices & Instruments industry
Industry Median: 2.65 vs XSWX:AFX: 5.82

A closely related ratio is called PB Ratio. As of today, Carl Zeiss Meditec AG's share price is CHF29.80. Carl Zeiss Meditec AG's Book Value per Sharefor the quarter that ended in Dec. 2025 was CHF0.00. Hence, Carl Zeiss Meditec AG's P/B Ratio of today is .


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Carl Zeiss Meditec AG Price-to-Tangible-Book Related Terms


Carl Zeiss Meditec AG Price-to-Tangible-Book Historical Data

* Premium members only.

The historical data trend for Carl Zeiss Meditec AG's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG Price-to-Tangible-Book Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Price-to-Tangible-Book
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.90 12.04 0.00 0.00 0.00

Carl Zeiss Meditec AG Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

XSWX:AFX vs ISRG, BDX, RMD: Price-to-Tangible-Book Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG Price-to-Tangible-Book vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Price-to-Tangible-Book falls into.


XSWX:AFX
76GF Score
Carl Zeiss Meditec AG XSWX:AFX
Price-to-Tangible-Book is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carl Zeiss Meditec AG Price-to-Tangible-Book Calculation

Carl Zeiss Meditec AG's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Dec. 2025 )
=29.80/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Is Carl Zeiss Meditec AG (XSWX:AFX) Overvalued in 2026?

Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued. The current stock price of CHF29.80 is trading 56.4% below its estimated GF Value™ of CHF68.36.

Key valuation signals for XSWX:AFX:

  • Price-to-Tangible-Book:
  • GF Value™: CHF68.36 vs. price of CHF29.80 (56.4% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the XSWX:AFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Carl Zeiss Meditec AG Business Description

Address Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
76GF Score

Get the complete analysis for XSWX:AFX

Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF29.80
Price
CHF68.36
GF Value